Dermatology Times, February 2023 (Vol. 44. No. 02)

Clinicians should strive to address the unique medical and aesthetic challenges seen in vitiligo.

Uncombable hair syndrome (UHS) can cause distress for families, but dermatologists can help with the rare genetic disease diagnosis and management.

A recent study published in Clinical and Experimental Dermatology observed a link between menopause and rosacea and found that menopausal flushing can exacerbate and precipitate rosacea.

Linda Stein Gold, MD, and Jennifer Soung, MD, discuss available nonsteroidal treatment options for plaque psoriasis in this DermView series recap.

Aaron Farberg, MD, and Jeffrey Crowley, MD, take a closer look at the management and treatment of generalized pustular psoriasis.

This article reviews equity-indexed life insurance policies and structured notes, instruments that offer investment protection and growth potential.

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, discusses fragrances in skin care products.

This month's Legal Eagle column explores what information is required during an informed consent discussion.

It’s important to continuously look forward to our role in serving all patients and colleagues—especially those who are underrepresented.

Pemphigus is defined as a group of autoimmune, blistering disorders caused by circulating autoantibodies that bind to desmogleins, proteins that are vital to epidermal intercellular adhesion.

In basal cell carcinoma, the most common type of skin cancer accounting for 80% of all non-melanoma skin cancers, one of the leading options for cases that fall into this category is targeted treatment with Hedgehog pathway inhibitors.

Although Merkel cell carcinoma can develop undetected or at a metastasized site, it usually first appears as a painless lump or nodule on an area of the skin that has been exposed to the sun.

Patient enrollment is now open for the study conducted by late-stage biopharmaceutical company, Soligenix.

At the RAD 2022 Conference, Steve Xu, MD, MSc, explains how a wearable sensor can better track the progression of atopic dermatitis while a patient is sleeping.

Jonathan Silverberg, MD, PhD, MPHS, gives an overview of topical therapies for atopic dermatitis at the 2022 virtual RAD conference.

At the 2022 RAD virtual conference, a dermatologist examines treatment options for AD in various racial and ethnic groups.

At the 2022 RAD Conference, a Harvard University psychologist discusses ways that practitioners can help identify and treat children with adverse mental health outcomes as a result of atopic dermatitis.

Argyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.